Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$24,532,631
-$2,755,428 QoQ
Shares Held
1,018,797
+4.8% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
1.68%
of 13F equity value
Holder Rank
#250
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arnhold LLC holds $63,520,210 across 6 Drug Manufacturers - General names. PFE ranks #2 (38.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
439,943 | $25,349,515 | |
| 2 | PFE |
Pfizer Inc
This page
|
1,018,797 | $24,532,631 | |
| 3 | MRK |
Merck & Co., Inc.
|
46,498 | $5,974,993 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
22,952 | $2,899,755 | |
| 5 | JNJ |
Johnson & Johnson
|
10,958 | $2,783,003 | |
| 6 | NVS |
Novartis AG
|
12,636 | $1,980,313 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,532,631 | 1,018,797 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $27,288,059 | 971,797 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $23,898,945 | 959,797 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $19,785,169 | 776,498 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $18,719,630 | 772,262 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $17,572,833 | 693,482 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $20,129,531 | 758,746 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $18,882,742 | 652,479 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $18,151,297 | 648,724 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $19,726,032 | 710,848 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $16,410,847 | 570,019 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $18,570,489 | 559,858 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $13,028,295 | 355,188 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $13,115,364 | 321,455 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $11,701,525 | 228,367 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $10,715,379 | 244,867 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $12,838,376 | 244,867 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $12,920,549 | 249,576 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $9,512,423 | 161,091 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $12,050,756 | 280,185 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $17,123,375 | 437,267 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $18,261,912 | 504,055 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $9,004,462 | 244,620 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $11,313,461 | 308,269 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $14,147,179 | 432,635 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $10,615,525 | 325,231 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||